Delivery Order SPE2DB20D1051-SPE2DB23FD9CT
Award Date 8/29/23
Potential Completion Date 8/30/23
Potential Value $53
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $69,080 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 90 packages containing 240mg capsules of the pharmaceutical diltiazem hydrochloride with an extended release mechanism. Performance will take place in Conshohocken, Pennsylvania under a one-day period from September 13-14, 2023. The contract was awarded utilizing the Medical Prime Vendor Next...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $26,340 by the Defense Logistics Agency to provide 90 capsules of 120mg diltiazem extended release capsules. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning from September 26, 2023 through September 27, 2023. No major subcontractors or set aside designations...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at thirteen thousand one hundred seventy dollars against the Defense Logistics Agency's prime vendor contract. The delivery order is to provide ninety capsules of the pharmaceutical Diltiazem Hydrochloride Extended Release 120mg to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $10,690 firm fixed price delivery order by the Defense Logistics Agency to supply 90 packages of 240mg Diltiazem 24-hour extended release capsules. The order is to be fulfilled on September 12-13, 2023 with place of performance in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues such delivery orders...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at approximately $22,000 by the Defense Logistics Agency to provide 90 capsules of the pharmaceutical product Diltiazem HCl extended release 120mg. The order is to be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 10, 2023 in support of the Defense Logistics Agency's medical supply procurement programs. No subcontractors or set-aside...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, was awarded a $105,360 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 90 packages containing 120mg capsules of the pharmaceutical diltiazem hydrochloride for extended release over 24 hours. Performance will take place in Conshohocken, Pennsylvania under the agency's indefinite-delivery/indefinite-quantity pharmaceutical prime vendor contract, which establishes a comprehensive...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $52,680 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 90 packages containing 120mg capsules of the pharmaceutical diltiazem with a 24-hour extended release. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from September 1st through September 5th, 2023. The Defense Logistics Agency...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $28,340 delivery order by the Defense Logistics Agency to supply 90 packages of 240mg Diltiazem 24-hour extended release capsules. The order is to be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania under firm fixed pricing and is required to be completed within a single day, August 7th through August 8th, 2023. No subcontractors or set aside designations were indicated....
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $1,138 firm fixed price delivery order against the Defense Logistics Agency Troop Support Prime Vendor Pharmaceuticals contract to supply 100 capsules of the generic hypertension medication diltiazem hydrochloride extended release 60 mg. Performance will take place in Conshohocken, Pennsylvania under a one day period concluding on July 27, 2023. Funding is provided by the Defense Logistics Agency Troop Support...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $269.64 delivery order by the Defense Logistics Agency Troop Support Medical to provide 100 capsules of the pharmaceutical Diltiazem HCl ER 60mg. The order is to be fulfilled within three days, from August 18th to August 21st 2023, with performance taking place in Conshohocken, Pennsylvania under firm fixed pricing terms. No subcontractors or set aside designations were indicated. The Defense...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB23FD9CTDelivery Order
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $52,680 firm fixed price delivery order by the Defense Logistics Agency to supply 90 boxes containing 120mg capsules of the pharmaceutical diltiazem hydrochloride with an extended release mechanism. Performance will take place in Conshohocken, Pennsylvania under a one-day period concluding on August 30, 2023. The order is placed against an existing DLA pharmaceuticals contract vehicle to support the Agency's medical supply needs. No subcontractors or set aside designations were indicated.
Generated 12/18/23, 2:51 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $53 | 8/29/23 |